About Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome
Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome is a rare disease catalogued by Orphanet (ORPHA:502423). It is associated with the MSTO1 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome trials.
Search ClinicalTrials.gov for "Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome" or filter by Orphanet code ORPHA:502423 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome. Updated daily.